PR Newswire | Feb 24, 2021 09:02AM EST

Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp.

02/24 08:00 CST

DECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp.LEAD PLAINTIFF DEADLINE IS MARCH 16, 2021 NEW YORK, Feb. 24, 2021

NEW YORK, Feb. 24, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds all investors that a federal securities class action lawsuit was filed in the United States District Court for the Central District of California against Decision Diagnostics Corp. ("Decision Diagnostics" or "the Company") (OTCBB: DECN) on behalf of investors who purchased the Company's securities between March 3, 2020 and December 17, 2020, inclusive (the ''Class Period'').

Allinvestors who purchased sharesofDecision Diagnostics Corp. and incurred losses are urged to contact the firm immediately atclassmember@whafh.comor (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action orjoin the caseon our website,www.whafh.com.

If you have incurred losses in the shares of Decision Diagnostics Corp., youmay,no later than March 16, 2021,request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of Decision Diagnostics Corp.

CLICK HERE TO JOIN CASE

According to the filed Complaint, the Company made false and misleading statements to the market. Decision Diagnostics failed to develop a viable COVID-19 test in any form, let alone a test that could detect the virus in less than one minute. The Company was not capable of meeting the U.S. Food and Drug Administration's (FDA's) EUA testing requirements for its purported COVID-19 test. Despite this inability to meet FDA requirements, the Company touted an unrealistic time to market for its tests. Based on these facts, the Company's public statements were false and materially misleading throughout the class.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Contact:Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq.Gregory Stone, Director of Case and Financial AnalysisEmail: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.comTel: (800) 575-0735 or (212) 545-4774

View original content: http://www.prnewswire.com/news-releases/decision-diagnostics-corp-class-action-alert-wolf-haldenstein-adler-freeman--herz-llp--reminds-investors-that-a-federal-securities-class-action-lawsuit-has-been-filed-against-decision-diagnostics-corp-301234297.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP